Suppr超能文献

印度各邦癌症负担及其变化:1990-2016 年全球疾病负担研究。

The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.

出版信息

Lancet Oncol. 2018 Oct;19(10):1289-1306. doi: 10.1016/S1470-2045(18)30447-9. Epub 2018 Sep 12.

Abstract

BACKGROUND

Previous efforts to report estimates of cancer incidence and mortality in India and its different parts include the National Cancer Registry Programme Reports, Sample Registration System cause of death findings, Cancer Incidence in Five Continents Series, and GLOBOCAN. We present a comprehensive picture of the patterns and time trends of the burden of total cancer and specific cancer types in each state of India estimated as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 because such a systematic compilation is not readily available.

METHODS

We used all accessible data from multiple sources, including 42 population-based cancer registries and the nationwide Sample Registration System of India, to estimate the incidence of 28 types of cancer in every state of India from 1990 to 2016 and the deaths and disability-adjusted life-years (DALYs) caused by them, as part of GBD 2016. We present incidence, DALYs, and death rates for all cancers together, and the trends of all types of cancers, highlighting the heterogeneity in the burden of specific types of cancers across the states of India. We also present the contribution of major risk factors to cancer DALYs in India.

FINDINGS

8·3% (95% uncertainty interval [UI] 7·9-8·6) of the total deaths and 5·0% (4·6-5·5) of the total DALYs in India in 2016 were due to cancer, which was double the contribution of cancer in 1990. However, the age-standardised incidence rate of cancer did not change substantially during this period. The age-standardised cancer DALY rate had a 2·6 times variation across the states of India in 2016. The ten cancers responsible for the highest proportion of cancer DALYs in India in 2016 were stomach (9·0% of the total cancer DALYs), breast (8·2%), lung (7·5%), lip and oral cavity (7·2%), pharynx other than nasopharynx (6·8%), colon and rectum (5·8%), leukaemia (5·2%), cervical (5·2%), oesophageal (4·3%), and brain and nervous system (3·5%) cancer. Among these cancers, the age-standardised incidence rate of breast cancer increased significantly by 40·7% (95% UI 7·0-85·6) from 1990 to 2016, whereas it decreased for stomach (39·7%; 34·3-44·0), lip and oral cavity (6·4%; 0·4-18·6), cervical (39·7%; 26·5-57·3), and oesophageal cancer (31·2%; 27·9-34·9), and leukaemia (16·1%; 4·3-24·2). We found substantial inter-state heterogeneity in the age-standardised incidence rate of the different types of cancers in 2016, with a 3·3 times to 11·6 times variation for the four most frequent cancers (lip and oral, breast, lung, and stomach). Tobacco use was the leading risk factor for cancers in India to which the highest proportion (10·9%) of cancer DALYs could be attributed in 2016.

INTERPRETATION

The substantial heterogeneity in the state-level incidence rate and health loss trends of the different types of cancer in India over this 26-year period should be taken into account to strengthen infrastructure and human resources for cancer prevention and control at both the national and state levels. These efforts should focus on the ten cancers contributing the highest DALYs in India, including cancers of the stomach, lung, pharynx other than nasopharynx, colon and rectum, leukaemia, oesophageal, and brain and nervous system, in addition to breast, lip and oral cavity, and cervical cancer, which are currently the focus of screening and early detection programmes.

FUNDING

Bill & Melinda Gates Foundation; and Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare, Government of India.

摘要

背景

之前报告印度及其不同地区癌症发病和死亡估计数的工作包括国家癌症登记计划报告、抽样登记系统死因调查结果、《五大洲癌症发病率》系列以及 GLOBOCAN。我们提供了一幅全面的图景,展示了印度每个邦的总癌症和特定癌症类型的负担模式和时间趋势,这些数据是作为全球疾病、伤害和危险因素研究(GBD)2016 一部分进行估计的,因为没有这样的系统汇编。

方法

我们使用了包括 42 个基于人群的癌症登记处和印度全国性抽样登记系统在内的多个来源的所有可获得的数据,以估计印度每个邦 1990 年至 2016 年 28 种癌症的发病情况以及由这些癌症导致的死亡和伤残调整生命年(DALY),这些数据都是 GBD 2016 的一部分。我们展示了所有癌症的发病率、DALY 和死亡率,以及所有类型癌症的趋势,突出了印度各邦特定类型癌症负担的异质性。我们还展示了主要危险因素对印度癌症 DALY 的贡献。

结果

2016 年,印度癌症死亡人数占总死亡人数的 8.3%(95%置信区间[UI]为 7.9-8.6),占总 DALY 的 5.0%(4.6-5.5),是 1990 年的两倍。然而,在此期间,癌症的年龄标准化发病率并没有显著变化。2016 年,印度各邦的癌症年龄标准化 DALY 率差异达 2.6 倍。2016 年,导致印度癌症 DALY 最高的 10 种癌症是胃癌(占总癌症 DALY 的 9.0%)、乳腺癌(8.2%)、肺癌(7.5%)、唇和口腔癌(7.2%)、咽(不包括鼻咽癌)(6.8%)、结肠和直肠(5.8%)、白血病(5.2%)、宫颈癌(5.2%)、食管癌(4.3%)和脑和神经系统癌症(3.5%)。在这些癌症中,乳腺癌的年龄标准化发病率从 1990 年到 2016 年显著增加了 40.7%(95%UI 为 7.0-85.6),而胃癌(39.7%;34.3-44.0)、唇和口腔癌(6.4%;0.4-18.6)、宫颈癌(39.7%;26.5-57.3)和食管癌(31.2%;27.9-34.9)以及白血病(16.1%;4.3-24.2)的发病率则有所下降。我们发现,2016 年不同类型癌症的年龄标准化发病率在各邦之间存在显著的异质性,发病率最高的四种癌症(唇和口腔、乳腺癌、肺癌和胃癌)的差异达 3.3 倍至 11.6 倍。烟草使用是印度癌症的主要危险因素,占 2016 年癌症 DALY 的最高比例(10.9%)。

解释

在过去的 26 年里,印度各邦癌症发病和健康损失趋势的巨大差异应该引起重视,以加强国家和邦两个层面的癌症预防和控制基础设施和人力资源。这些努力应该集中在导致印度 DALY 最高的十种癌症上,包括胃癌、肺癌、咽(不包括鼻咽癌)、结肠和直肠、白血病、食管癌和脑和神经系统,以及乳腺癌、唇和口腔癌和宫颈癌,这些癌症目前是筛查和早期检测计划的重点。

资金

比尔及梅琳达·盖茨基金会;以及印度医学研究理事会,印度卫生部,印度政府。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d817/6167407/5a258f061b04/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验